Effects of Chiropractic on Chronic Cancer-related Fatigue
CAN
The Effects of Upper Cervical Chiropractic Care in Adult Cancer Survivors With Chronic Cancer-related Fatigue: a Feasibility Trial
1 other identifier
interventional
20
1 country
1
Brief Summary
The primary aims of the proposed trial are centered around examining the feasibility of conducting a prospective, chiropractic intervention study on a population of cancer survivors living in and around Atlanta, Georgia. This includes evaluating various implementation outcomes including recruitment, adherence, tolerability, retention, acceptability, and data fidelity. The results of this trial will inform the design of a future randomized controlled trial (RCT) that has an increased focus on the efficacy/effectiveness of chiropractic care on chronic cancer-related fatigue (CCRF) and other cancer-related sequelae in cancer survivors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable cancer
Started Mar 2024
Shorter than P25 for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 23, 2024
CompletedFirst Posted
Study publicly available on registry
February 1, 2024
CompletedStudy Start
First participant enrolled
March 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedFebruary 1, 2024
January 1, 2024
6 months
January 23, 2024
January 31, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
Participant recruitment
Average number of participants recruited/enrolled per month
6-month data collection period
Participant scheduling
Average time lag between first lab assessment \& first chiropractic visit
6-month data collection period
Participant compliance
Proportion of participants violating 1 or more pre-assessment lifestyle restrictions \& unable/unwilling to be rescheduled
6-month data collection period
Participant adherence
Proportion of participants not attending at least 80% of their chiropractic sessions
6-month data collection period
Participant tolerability
Proportion of participants unable/unwilling to complete a given assessment
6-month data collection period
Participant retention
Proportion of participants completing the trial
6-month data collection period
Assessment acceptability
Most common patient-related acceptability score for each assessment process/procedure
6-month data collection period
Data fidelity
Proportion of acquisitions from a given assessment that are unsuitable for analysis
6-month data collection period
Implementation acceptability
Most common clinician-rated acceptability score for each trial process/procedure
6-month data collection period
Study Arms (1)
Chiropractic intervention
EXPERIMENTALUpper cervical chiropractic care
Interventions
Eligibility Criteria
You may qualify if:
- Able to understand and provide written informed consent in English
- years of age
- Informed by primary health care provider that there is no evidence of active disease (this is sometimes referred to as "complete remission" or "cured")
- Minimum of 3 months since completion of primary curative-intent cancer therapies including surgery, chemotherapy, radiotherapy, and/or immunotherapy (long-term hormonal therapy permitted)
- Onset of fatigue occurred at some point during illness and/or treatment
- FACIT-Fatigue scale score in the moderate-to-severe range (i.e., at or above the 60th percentile)
- If on any prescription medication (including hormonal therapy), on a stable dose for a minimum of 12 weeks with no plans to change medications or doses during the study
You may not qualify if:
- Taking any short-acting benzodiazepine including midazolam \& triazolam
- Known disorder resulting in syncope/fainting during postural changes (e.g., postural orthostatic tachycardia syndrome, orthostatic hypotension)
- Pacemaker or known heart condition that influences the electrical or mechanical function of the heart (e.g., severe heart valve disease)
- Diagnosed with an externalizing (e.g., substance use, antisocial disorder) or thought (e.g., schizophrenia, paranoid personality, bipolar) disorder that is uncontrolled or untreated
- Diagnosed with rheumatoid arthritis, osteoporosis, or cervical spine instability
- Currently pregnant
- Current litigation related to a physical, health-related injury
- Chronic pain rated at least 3/10 on a visual analog scale (VAS)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Life Universitylead
Study Sites (1)
Dr. Sid E. Williams Center for Chiropractic Research
Atlanta, Georgia, 30308, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yori Gidron, PhD
University of Haifa
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 23, 2024
First Posted
February 1, 2024
Study Start
March 1, 2024
Primary Completion
September 1, 2024
Study Completion
December 31, 2024
Last Updated
February 1, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share